# Bioequivalence Study of GZR18 Injection Before and After CMC Change

> **NCT07355738** · PHASE1 · RECRUITING · sponsor: **Gan & Lee Pharmaceuticals.** · enrollment: 138 (estimated)

## Conditions studied

- Obesity&T2D

## Interventions

- **DRUG:** GZR18 injection A
- **DRUG:** GZR18 injection B

## Key facts

- **NCT ID:** NCT07355738
- **Lead sponsor:** Gan & Lee Pharmaceuticals.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-09
- **Primary completion:** 2026-05-20
- **Final completion:** 2026-05-20
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07355738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07355738, "Bioequivalence Study of GZR18 Injection Before and After CMC Change". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT07355738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*